Skip to main content

Table 3 Perioperative Variables and Postoperative Complications of the Study Population

From: Thrombotic gene polymorphisms and postoperative outcome after coronary artery bypass graft surgery

 

Study population

(n = 220)

FVL 1691 G/G

(n = 196)

FVL 1691 G/A

(n = 24)

p value*

PT 20210 G/G

(n = 212)

PT 20210 G/A

(n = 8)

p value**

ACE I/I & I/D

(n = 124)

ACE D/D

(n = 57)

p value***

CPB time (min)

77.5 ± 15.7

77.5 ± 15.7

77.3 ± 15.9

NS

77.5 ± 15.9

77.5 ± 9.0

NS

79.2 ± 17.5

75.2 ± 11.5

NS

Number of coronary grafts

3.0 ± 1.1

3.0 ± 1.1

3.0 ± 0.9

NS

3.0 ± 1.1

2.4 ± 0.9

NS

3.1 ± 1.1

2.9 ± 1.0

NS

Postoperative blood loss at 24 hours, mL

463.5 ± 155.1

487.1 ± 150.5

460.6 ± 155.7

NS

459.6 ± 133.6

566.9 ± 449.0

NS

448.5 ± 136.0

470.9 ± 130.5

NS

Total drainage, mL

604.3 ± 204.1

597.4 ± 191.5

660.4 ± 286.3

NS

599.6 ± 176.5

730.0 ± 587.9

NS

581.1 ± 179.8

631.9 ± 187.4

0.045

Stay in intensive care unit, hours

54.9 ± 80.4

56.6 ± 85.0

42.0 ± 9.1

NS

52.9 ± 73.4

109.6 ± 190.3

NS

56.3 ± 82.7

53.0 ± 60.4

NS

In-hospital Mortality, %

6 (2.7)

6 (3.1)

0

NS

5 (2.4)

1 (12.5)

NS

3 (2.4)

2 (3.5)

NS

  1. * FVL 1691G/G compared with FVL 1691 G/A polymorphism; ** PT 20210 G/G compared with PT 20210 G/A polymorphism; *** ACE I/I and ACE I/D group compared with ACE D/D polymorphism group.